Low-dose intravenous pamidronate treatment in osteogenesis imperfecta
Makaleler > Tam Makale · 2006
Yazarlar: Ruhsar Damla GÖKŞEN, Mahmut ÇOKER, Şükran DARCAN, Timur KÖSE, Serdar KARA
TURKISH JOURNAL OF PEDIATRICS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2006, cilt 48, ss 124-129
Özet
Different therapy models have been tried in order to decrease bone resorption in osteogenesis imperfecta. Bisphosphonates are a group of drugs that mainly suppress osteoclast-mediated bone resorption, thus reducing bone turnover. We assessed the effects of low-dose bisphosphonate treatment in children with osteogenesis imperfecta.